Stay updated on Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added and the v3.5.0 revision was removed from the record history.
    Difference
    0.1%
    Check dated 2026-04-16T10:38:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:58:08.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the page history. This appears to be a UI/site version update and does not modify trial data or study contents.
    Difference
    0.1%
    Check dated 2026-03-11T16:42:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added a new revision entry: v3.4.2; removed the funding-lapse notice and an older revision entry (v3.4.1).
    Difference
    0.7%
    Check dated 2026-02-11T02:04:48.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A government funding lapse notice was added to the page. The site revision was updated to v3.4.1, and the previous revision v3.4.0 was removed.
    Difference
    0.7%
    Check dated 2026-02-04T00:00:17.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now includes a Show glossary option and explanatory color-coding for additions and deletions (green for additions, red for deletions). It also shows the Revision: v3.4.0 and introduces the No FEAR Act Data labeling.
    Difference
    0.9%
    Check dated 2026-01-27T21:55:29.000Z thumbnail image

Stay in the know with updates to Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.